MedTrace Logo

Juanbi Pill for Rheumatoid Arthritis

NCT02885597 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2018-07-17

No results posted yet for this study

Summary

The purpose of this study is to determine whether Juanbi Pill combined with methotrexate are effective in the treatment of active Rheumatoid Arthritis (RA).

Conditions

Interventions

DRUG

Juanbi pill

4g, twice a day, 3month, oral

DRUG

Juanbi pill placebo

4g, twice a day, 3month, oral

DRUG

Methotrexate

5mg, once a week, 3 month, oral

Sponsors & Collaborators

  • Shanghai Yueyang Integrated Medicine Hospital

    collaborator OTHER

  • Longhua Hospital

    collaborator OTHER

  • Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine

    collaborator OTHER

  • Cui xuejun

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-31
Primary Completion
2018-12-31
Completion
2020-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02885597 on ClinicalTrials.gov